Weekly Watch List

ALXN (7/24/11, +43.49%)
GNC (2/19/12, +0.59%)
LQDT (12/25/11, +22.43%)
ULTA (11/13/11, +13.26%)
MA (9/24/11, +23.32%)
FIRE (2/26/12, +0.00%)
MNST (10/16/11, +19.50%)
NUS (8/28/11, +39.17%)
DLTR (9/4/11, +23.33%)
GWW (1/15/12, +5.38%)
GOLD (2/26/12, +0.00%)
CXO (1/29/12, +6.41%)
HMSY (2/26/12, +0.00%)
TJX (2/12/12, +4.69%)

Additions:
FIRE (2/26/12, +0.00%)
GOLD (2/26/12, +0.00%)
HMSY (2/26/12, +0.00%)

Subtractions:
CFX (2/12/12, +6.29%)

Last week, the major U.S. indexes slogged ahead. The NYSE composite added 0.5%, the Nasdaq gained 0.4%, and the S&P 500 and Dow each tacked on 0.3%. The IBD outlook remains at “confirmed uptrend”. There wasn’t any distribution last week, but there wasn’t any accumulation on volume either, which could indicate the market is stalling out. Still, with the skyrocketing price of oil and the looming threat of military action against Iran, the market is holding up better than might be expected. In any case, ignore the background noise and focus on the actual market action which, at the moment, is telling you that the uptrend is still intact.

This week, two watch list stocks are at or near proper buy points. NUS, trading at $53.86, has drifted back down to within 5% of a $51.77 buy point, working from a 3rd stage flat base. DLTR, trading at $87.82, is just above a $86.74 buy point off of a three weeks tight pattern.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

ALXN (7/24/11, +37.33%)
GNC (2/19/12, +0.00%)
ULTA (11/13/11, +14.11%)
LQDT (12/25/11, +17.43%)
NUS (8/28/11, +40.57%)
MA (9/24/11, +17.50%)
DLTR (9/4/11, +25.47%)
MNST (10/16/11, +12.75%)
CXO (1/29/12, +7.65%)
GWW (1/15/12, +6.19%)
CFX (2/12/12, +6.29%)
TJX (2/12/12, +1.48%)

Additions:
GNC (2/19/12, +0.00%)

Subtractions:
AAP (12/11/11, +21.76%)
AUY (1/8/12, +9.79%)
DG (9/4/11, +17.53%)
GOLD (12/11/11, +2.34%)

Last week, the major U.S. indexes resumed their upward trend. The Nasdaq advanced 1.6%, the NYSE composite added 1.5%, the S&P 500 gained 1.4%, and the Dow moved up 1.2% The IBD outlook remains at “confirmed uptrend”. The markets flashed some signs of distribution but not enough to put the current uptrend under pressure. It’s still okay to make new purchases but keep in mind that this rally is starting to get long in the tooth and some type of pullback wouldn’t be all that surprising to see.

This week, two watch list stocks are at or near proper buy points. MA, trading at $396.00, is still within 5% of a $385.09 buy point after breaking out of a 2nd stage flat base. DLTR, trading at $89.35, is still within 5% of a $86.74 buy point off of a three weeks tight pattern.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

ALXN (7/24/11, +41.48%)
ULTA (11/13/11, +11.73%)
LQDT (12/25/11, +11.57%)
MA (9/24/11, +17.54%)
DLTR (9/4/11, +21.94%)
NUS (8/28/11, +37.73%)
DG (9/4/11, +18.94%)
MNST (10/16/11, +14.75%)
CXO (1/29/12, +3.87%)
AAP (12/11/11, +13.82%)
GOLD (12/11/11, +3.74%)
GWW (1/15/12, +1.76%)
TJX (2/12/12, +0.00%)
CFX (2/12/12, +0.00%)
AUY (1/8/12, +8.52%)

Additions:
CFX (2/12/12, +0.00%)
TJX (2/12/12, +0.00%)

Subtractions:
NSR (2/5/12, -2.03%)

Last week, the major U.S. indexes ended their weeks long winning streak and turned lower. The Nasdaq inched down 0.1%, the S&P 500 faded 0.2%, the Dow gave back 0.5%, and the NYSE composite lost 0.8%. The IBD outlook remains at “confirmed uptrend”. Once again, Greece reared it’s ugly head on Friday and sealed the week’s fate. After so many weeks of run up, it would be perfectly normal to see some kind of pullback in the near future. That said, at this point at least, there is almost no evidence of distribution that would indicate market-moving institutions are in a mood to sell. Keep an eye over your shoulder but continue to ride the tape until the market itself tells you to dismount.

This week, five watch list stocks are at or near proper buy points. MA, trading at $396.14, is still within 5% of a $385.09 buy point after breaking out of a 2nd stage flat base. DLTR, trading at $86.83, has formed and broken past another three weeks tight pattern with a buy point of $86.74. NUS, trading at $53.30, is still within 5% of a $51.77 buy point after breaking out of a 3rd stage flat base. DG, trading at $42.89, broke out of a 2nd stage flat base with a $42.20 buy point, but volume is lacking. CFX, trading at $33.57, found good support at its 10 week line and is in buy range up to $35.62.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

LQDT (12/25/11, +11.49%)
ALXN (7/24/11, +33.73%)
ULTA (11/13/11, +7.96%)
MA (9/24/11, +15.81%)
AUY (1/8/12, +14.18%)
DLTR (9/4/11, +20.28%)
NUS (8/28/11, +36.33%)
MNST (10/16/11, +12.01%)
GOLD (12/11/11, +7.06%)
DG (9/4/11, +16.31%)
AAP (12/11/11, +9.45%)
CXO (1/29/12, +1.80%)
GWW (1/15/12, +3.23%)
NSR (2/5/12, +0.00%)

Additions:
NSR (2/5/12, +0.00%)

Subtractions:
RGLD (10/30/11, +1.30%)
TJX (11/27/11, +17.55%)
VRSK (12/18/11, +3.07%)

Last week, the major U.S. indexes moved higher. The Nasdaq and the S&P 500 each rose 3.2%, the NYSE composite added 2.3%, and the Dow was up 1.6%. The IBD outlook remains at “confirmed uptrend”.

This week, five watch list stocks are at or near proper buy points. ULTA, trading at $78.11, is still within 5% of a $75.80 buy point after breaking out of a 4th stage cup base and volume is still lacking. MA, trading at $390.32, broke out of a 2nd stage flat base and is sitting just above a $385.09 buy point. DLTR, trading at $85.65, is still just above a $84.09 buy point off of a three weeks tight pattern. NUS, trading at $52.76, broke out of a 3rd stage flat and is just past a $51.77 buy point. CXO, trading at $108.49, broke out of a 3rd stage cup with handle base and is still within 5% of a$104.93 buy point.

/as usual, your mileage may vary, always do your own homework